Wednesday, May 12, 2021

A C.D.C. advisory panel recommends the Pfizer-BioNTech vaccine be made available to 12- to 15-year-olds.


By BY APOORVA MANDAVILLI from NYT Health https://ift.tt/33B3aS4

No comments:

Post a Comment